Loading...
XNAS
BGLC
Market cap5mUSD
May 16, Last price  
2.85USD
1D
-6.25%
1Q
668.19%
IPO
595.12%
Name

BioNexus Gene Lab Corp

Chart & Performance

D1W1MN
P/E
P/S
0.52
EPS
Div Yield, %
Shrs. gr., 5y
23.49%
Rev. gr., 5y
115.07%
Revenues
10m
-10.60%
0107,680212,328126,95511,390,44013,362,56710,928,7079,770,806
Net income
-3m
L+638.57%
-835-123,75026,454-246,4691,094,098751,571-355,966-2,629,043
CFO
-1m
L
-835357,216-274,080-217,273552,6809,161544,028-1,301,595

Profile

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
IPO date
Mar 11, 2020
Employees
27
Domiciled in
MY
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
9,771
-10.60%
10,929
-18.21%
Cost of revenue
12,850
11,399
Unusual Expense (Income)
NOPBT
(3,080)
(470)
NOPBT Margin
Operating Taxes
22
52
Tax Rate
NOPAT
(3,101)
(523)
Net income
(2,629)
638.57%
(356)
-147.36%
Dividends
(115)
Dividend yield
Proceeds from repurchase of equity
5,750
150
BB yield
Debt
Debt current
35
17
Long-term debt
232
97
Deferred revenue
(31)
Other long-term liabilities
31
Net debt
(7,362)
(3,156)
Cash flow
Cash from operating activities
(1,302)
544
CAPEX
(149)
(54)
Cash from investing activities
(383)
(450)
Cash from financing activities
5,754
116
FCF
(132)
(1,132)
Balance
Cash
5,929
2,119
Long term investments
1,700
1,151
Excess cash
7,141
2,723
Stockholders' equity
14,670
11,677
Invested Capital
2,651
3,998
ROIC
ROCE
EV
Common stock shares outstanding
15,875
14,410
Price
Market cap
EV
EBITDA
(2,971)
(365)
EV/EBITDA
Interest
14
12
Interest/NOPBT